Skip to main content

Mates Sharon's Form 4 filing

Intra-Cellular Therapies, Inc. (ITCI) · filed Aug 23, 2024

Accession no.
0000950170-24-100275
Filed
Aug 23, 2024
Trade date
Aug 21-23, 2024
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 10 non-derivative transactions and 3 derivative transactions. Open-market sales total $9.09M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Mates SharonCIK 0001585699Director, Officer (Chairman and CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 21, 2024Common StockMOption exerciseAcquired+53,013$17.57+$931,438.411,123,342Direct
Aug 21, 2024Common StockSSaleDisposed−44,134$75.40−$3,327,703.61,079,208Direct
Aug 21, 2024Common StockSSaleDisposed−4,297$76.20−$327,431.41,074,911Direct
Aug 21, 2024Common StockSSaleDisposed−2,682$77.21−$207,077.221,072,229Direct
Aug 21, 2024Common StockSSaleDisposed−1,900$77.98−$148,1621,070,329Direct
Aug 22, 2024Common StockMOption exerciseAcquired+39,380$17.57+$691,906.61,109,709Direct
Aug 22, 2024Common StockSSaleDisposed−35,011$74.58−$2,611,120.381,074,698Direct
Aug 22, 2024Common StockSSaleDisposed−4,369$75.47−$329,728.431,070,329Direct
Aug 23, 2024Common StockMOption exerciseAcquired+28,680$17.57+$503,907.61,099,009Direct
Aug 23, 2024Common StockSSaleDisposed−28,680$74.46−$2,135,512.81,070,329Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 21, 2024Common StockMOption exerciseDisposed−53,013$0.00$0163,985Direct
Aug 22, 2024Common StockMOption exerciseDisposed−39,380$0.00$0124,605Direct
Aug 23, 2024Common StockMOption exerciseDisposed−28,680$0.00$095,925Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)